ArticleTissue engineering. Part A2022

Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss.

Jennifer McFaline-Figueroa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.